Ashish Patel
Pediatric Gastroenterology · Phoenix, AZNPI 1053421636
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $69,790 of the $94,333 with a category attached, or 74.0%. AbbVie accounts for 80.0% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2021 at $55,666 and has fallen 94.2% since, to $3,218 in 2025. Among pediatric gastroenterology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 197 payments — averaging $478.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$75K
- Abbott$6K
- Pfizer$5K
- Celltrion USA Inc.$3K
- QOL Medical, LLC$2K
- Janssen Scientific Affairs, LLC$485
- plus $3K from 19 others
Across 126 payments — averaging $2882.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$210K
- AbbVie$117K
- Janssen Research & Development, LLC$19K
- Genentech, Inc.$16K
What the payments were for
- Consulting fees$9,56510%
- Speaking & faculty fees$69,79074%
- Grants$1,5002%
- Travel & lodging$5,0065%
- Food & beverage$8,3069%
- Education$1650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 117 | $75,452 |
| Abbott | 10 | $6,475 |
| Pfizer | 4 | $4,580 |
| Celltrion USA Inc. | 1 | $2,590 |
| QOL Medical, LLC | 18 | $2,114 |
| Janssen Scientific Affairs, LLC | 7 | $485 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $384 |
| Bristol Myers Squibb | 3 | $343 |
| Ipsen Biopharmaceuticals, Inc | 3 | $306 |
| Johnson & Johnson | 6 | $301 |
| Mirum Pharmaceuticals, Inc. | 3 | $287 |
| Perspectum Diagnostics Ltd | 1 | $194 |
| Sanofi | 2 | $161 |
| Biogen | 1 | $150 |
| E.r. Squibb & Sons, L.L.C. | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 1 | $111 |
| Lilly USA, LLC | 4 | $83 |
| AstraZeneca | 2 | $47 |
| Orphalan Inc | 1 | $36 |
| Medtronic | 1 | $29 |
| Alcresta Therapeutics, Inc. | 1 | $27 |
| Evoendo, Inc | 1 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| Albireo Pharma, Inc. | 1 | $15 |
| Travere Therapeutics, Inc. | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$94,333 in reported general payments places this provider in the 90th percentile of 45 pediatric gastroenterology providers in Arizona.
Other pediatric gastroenterology in Phoenix
- Shauna SchroederPhoenix$424K
- Paula PrietoPhoenix$167K
- Brad PasternakPhoenix$136K
- Joseph WoolleyPhoenix$16K
- Paul TranPhoenix$8K
- Eric DybbroPhoenix$5K
- Gary SilberPhoenix$4K
- Sheetal WaderaPhoenix$4K
- Michael FinchPhoenix$3K
- Elizabeth HilowPhoenix$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.